TAM
BPMC

Thematics Asset Management’s Blueprint Medicines BPMC Stock Holding History

Thematics Asset Management’s Portfolio BPMC Stock Details BPMC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-37,601
Closed -$3.33M – 127
2025
Q1 		$3.33M Buy
37,601
+36,775
+4,452% +$3.59M 0.17% 117
2024
Q4 		$72K Buy
+826
New +$75.7K ﹤0.01% 132

Other funds holding BPMC

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Thematics Asset Management's BPMC Position: Q2 2025 in Review

Thematics Asset Management sold out of Blueprint Medicines (BPMC) in Q2 2025, closing a stake of 37,601 shares — an estimated $3.33M sold.

Thematics Asset Management first reported a position in BPMC in Q4 2024 and held it in 2 quarters. The position peaked at $3.33M in Q1 2025. 354 funds tracked by Wall St. Rank hold BPMC as of Q2 2025.

  • Thematics Asset Management reported no remaining Blueprint Medicines position as of Q2 2025 after selling out during the quarter.
  • Thematics Asset Management sold 37,601 Blueprint Medicines shares in Q2 2025, an estimated $3.33M.
  • Thematics Asset Management first reported a position in Blueprint Medicines in Q4 2024 and held it in 2 quarters.
  • Thematics Asset Management's Blueprint Medicines position peaked at $3.33M in Q1 2025.
  • 354 funds tracked by Wall St. Rank held Blueprint Medicines as of Q2 2025.

Based on Thematics Asset Management's 13F filing for Q2 2025, filed 13 Aug 2025.